Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Leukemia
|
July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
S K Kumar, J H Lee, J J Lahuerta, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Leukemia
|
July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
S K Kumar, J H Lee, J J Lahuerta, et al.
Leukemia
|
July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
P Moreau, M Attal, F Garban, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Page
of 5